Importantly, our ssGSEA data supported this because comparison of the CD8 T cell score in IDH-wildtype and -mutant gliomas revealed a significant suppression of these immune cells in the latter (Figure S5), consistent with findings from other studies [27]. Here, IDH2 is linked to central nervous system cancer.